The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Anderson, Sarah Jennifer
    Individual (8 offsprings)
    Officer
    2004-03-22 ~ now
    OF - Secretary → CIF 0
  • 2
    Anderson, Richard James
    Director born in April 1966
    Individual (21 offsprings)
    Officer
    2004-03-22 ~ now
    OF - Director → CIF 0
  • 3
    BRAEMAR PHARMA LTD - 2024-11-20
    DERM NEWCO LIMITED - 2020-05-28
    Ground Floor, 3 Royal Court, Tatton Street, Knutsford, Cheshire, England
    Active Corporate (1 parent, 1 offspring)
    Equity (Company account)
    -839,475 GBP2024-03-31
    Person with significant control
    2020-06-09 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
Ceased 2
  • 1
    Mr Richard James Anderson
    Born in April 1966
    Individual (21 offsprings)
    Person with significant control
    2016-04-06 ~ 2020-06-09
    PE - Ownership of shares – 75% or moreCIF 0
  • 2
    Kerry, Spencer Alan
    Director born in September 1974
    Individual
    Officer
    2020-06-09 ~ 2022-09-28
    OF - Director → CIF 0
parent relation
Company in focus

J J S PHARMA (UK) LIMITED

Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Average Number of Employees
02023-04-01 ~ 2024-03-31
02022-04-01 ~ 2023-03-31
Par Value of Share
Class 1 ordinary share
12023-04-01 ~ 2024-03-31
Total Inventories
115,400 GBP2024-03-31
110,146 GBP2023-03-31
Debtors
256,713 GBP2024-03-31
225,512 GBP2023-03-31
Cash at bank and in hand
10,443 GBP2024-03-31
6,728 GBP2023-03-31
Current Assets
382,556 GBP2024-03-31
342,386 GBP2023-03-31
Creditors
Current
269,546 GBP2024-03-31
246,768 GBP2023-03-31
Net Current Assets/Liabilities
113,010 GBP2024-03-31
95,618 GBP2023-03-31
Total Assets Less Current Liabilities
113,010 GBP2024-03-31
95,618 GBP2023-03-31
Equity
Called up share capital
1 GBP2024-03-31
1 GBP2023-03-31
Retained earnings (accumulated losses)
113,009 GBP2024-03-31
95,617 GBP2023-03-31
Equity
113,010 GBP2024-03-31
95,618 GBP2023-03-31
Trade Debtors/Trade Receivables
Amounts falling due within one year, Current
250,453 GBP2024-03-31
225,512 GBP2023-03-31
Other Debtors
Amounts falling due within one year, Current
6,260 GBP2024-03-31
Debtors
Amounts falling due within one year, Current
256,713 GBP2024-03-31
225,512 GBP2023-03-31
Trade Creditors/Trade Payables
Current
17,755 GBP2024-03-31
19,330 GBP2023-03-31
Amounts owed to group undertakings
Current
39,634 GBP2024-03-31
47,298 GBP2023-03-31
Other Taxation & Social Security Payable
Current
2,409 GBP2023-03-31
Other Creditors
Current
212,157 GBP2024-03-31
177,731 GBP2023-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1 shares2024-03-31

  • J J S PHARMA (UK) LIMITED
    Info
    Registered number 05080170
    12 Rutherford Drive, Knutsford WA16 8GX
    Private Limited Company incorporated on 2004-03-22 (21 years 3 months). The company status is Active.
    The last date of confirmation statement was made at 2024-03-22
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.